23/05/2014 - 19:35
The investigational monoclonal antibody etrolizumab effected clinical remission in significantly more patients with refractory ulcerative colitis than did placebo, an industry-sponsored trial...
Field of Interest: Gastroentero...
Categories:
News Feed: Internal Medicine News - Gastroenterology